February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
January 31, 2019 — Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target ...
January 31, 2019
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral ...
January 30, 2019
Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...
January 14, 2019
January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets ...
January 10, 2019
Feature | Dave Fornell, Editor
January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...
January 04, 2019
January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...
January 03, 2019
January 2, 2019 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval ...
January 02, 2019
December 17, 2018 — Among otherwise healthy people, a daily dose of aspirin does not save lives and causes additional ...
December 17, 2018
December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all ...
December 11, 2018
December 7, 2018 — New data from the Phase 3 CASSINI study showed a 60 percent reduction of venous thromboembolism (VTE ...
December 07, 2018
November 30, 2018 — Healthcare technology company Livongo recently announced the launch of its Applied Health Signals ...
November 30, 2018
November 16, 2018 — A research team led by scientists and doctors in Leicester and the Netherlands has shown that a ...
November 19, 2018
November 15, 2018 — AstraZeneca announced positive full results from the DECLARE-TIMI 58 cardiovascular (CV) outcomes ...
November 15, 2018
Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital ...
November 13, 2018